Answers
Medicare GLP-1 Bridge, answered.
Plain answers to the questions people ask most — then a one-minute check to see where you land.
→Does Medicare cover Wegovy?Yes — as of July 1, 2026, Wegovy is covered for weight loss at a $50 monthly copay for eligible Medicare Part D members through the GLP-1 Bridge pilot program, which runs through December 31, 2027.
→Does Medicare cover Zepbound?Yes — the KwikPen formulation of Zepbound is covered for weight loss at a $50 monthly copay for eligible Medicare Part D members under the GLP-1 Bridge pilot, effective July 1, 2026 through December 31, 2027.
→Does Medicare cover Ozempic or Mounjaro for weight loss?No — Ozempic and Mounjaro are not covered by the Medicare GLP-1 Bridge program.
→Who qualifies for Medicare's $50 GLP-1 copay?You qualify for the $50 GLP-1 copay if you have Medicare Part D and meet one of three BMI-and-condition profiles under the Bridge program — and you do not already have a condition Medicare covers a GLP-1 for.
→Am I eligible for the Medicare GLP-1 Bridge?You are likely eligible if you have Medicare Part D and a BMI of 30 or higher (or 27+ with a qualifying condition like prediabetes or a past cardiac event) — and you don't already have type 2 diabetes, sleep apnea, or MASH.
→Is Foundayo covered by Medicare?Yes — all formulations of Foundayo are covered for weight loss at a $50 monthly copay for eligible Medicare Part D members under the GLP-1 Bridge pilot, from July 1, 2026 through December 31, 2027.